Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 24.97 2.71%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Rigel Pharmaceuticals Accounts Receivables 2011-2024 | RIGL

Annual Accounts Receivables Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
30.6 M 40.3 M 15.5 M 16 M 10.1 M 4.08 M - - 203 K 5.75 M 5.75 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
40.3 M 203 K 14.2 M

Quarterly Accounts Receivables Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
30.6 M 28.9 M 27.5 M 23.5 M 20.8 M 29.4 M 40.3 M 15.5 M - 15.2 M 15.5 M 15 M 17.4 M 142 M 16 M 16 M 16 M 16 M 10.1 M 10.1 M 10.1 M 10.1 M 4.08 M 4.08 M 4.08 M 4.08 M - - - - - - 95 K 195 K 203 K 203 K 203 K 203 K 5.75 M 5.75 M 5.75 M 5.75 M 5.75 M 5.75 M 5.75 M 5.75 M - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
142 M 95 K 15.1 M